(GPFT), (LOWLF) – Cannabis Movers & Shakers: Mindset Pharma, Better Plant, NeonMind, Urban-Gro, Lowell Farms, Vext Science, Grapefruit USA

Mindset Pharma types Dr. Joseph Gabriele on the advisory board

Mindset Pharma Inc. (CSE: MSET) (PINK: MSSTF) Dr. Joseph Gabriele, a molecular pharmacologist and co-founder of Delivra Corp., hired as a scientific advisor.

Prior to joining the advisory board of the Toronto-based company, Gabriele worked on developing delivraTM, a transdermal delivery platform, according to Psychedelic Finance.

His company Delivra is an industry partner of the National Research Council of Canada.

“Mindset will benefit greatly from Dr. Gabriele’s extensive drug and delivery product development experience, which will be of vital importance as Mindset advances its drug candidates toward clinical trials,” said CEO James Lanthier.

Better Plant Sciences appoint Perry Chua CCO

Vertically Integrated Wellness Asset Corporation Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF), formerly known as Yield Growth Corp., has promoted Perry Chua to Chief Creative Officer.

According to Psilocybin alpha, Chua has been the creative director of the Vancouver-based company since 2019.

He has over two decades of brand design experience and has worked with clients including Nokia (NYSE: NOK), McDonald’s Restaurants (NYSE: MCD), Mountain Equipment Co-op, Four Seasons Private Residences, Urban Barn and NGRAIN.

“We look forward to Perry using his exceptional creative abilities and unconventional thinking to lead his team in developing and advancing the Better Plant brands,” said the company’s CEO, Penny White, on Tuesday.

NeonMind Biosciences hires Philippe Martin to develop the psilocybin drug

NeonMind Biosciences Inc. (CSE: NEON) (PINK: NMDBF), a biotechnology company focused on the manufacture of fungal medicines, has hired Philippe Martin as a drug development consultant.

Martin worked in the biotechnology and pharmaceutical industries developing innovative therapies for 20 years. He focused on the areas of immunology, oncology and neurology.

In his new role, Martin will help advance the company’s two psilocybin drug development programs, which focus on weight loss and appetite suppression.

Martin currently served as director of clinical development and operations for BioAtla, Inc (NASDAQ: BCAB) in San Diego.

Prior to that, he held executive positions at Celgene for over a decade.

“Philippe will help us make the many decisions we must make to move synthetic psilocybin through the rigorous drug development process into an approved medical therapy,” noted Company President and CEO Robert Tessarolo.

Urban-Gro appoints Barbara Jacobs as VP of Marketing

Urban-gro Inc. (NASDAQ: UGRO) named Barbara Jacobs vice president of marketing shortly after James Dennedy was named president and chief operating officer.

Bradley Nattrass, CEO and chairman of the Lafayette, Colorado-based horticultural company, said Tuesday that Jacobs is ready to help develop and strengthen its “opportunity pipeline”.

“Barbara is a committed executive with many years of experience in the CEA sector,” commented Nattrass on Jacobs’ return to the Urban-gro team.

The company also chose to partner with Interius Farms on “growing fresh and sustainable food for the Canadian market,” explained Dennedy.

Lowell Farms appoints Bryan Dunmire as CPO

Cannabis company Lowell Farms Inc. (CSE: LOWL) (OTCQX: LOWLF), formerly known as Indus Holdings Inc., has hired Bryan Dunmire to oversee its production.

Dunmire joined the company in April as Senior Vice President of Strategy. He also oversaw the recent acquisition of Lowell Farms by Indus, as well as the name change and rebranding of the company.

Previously, he was Chief Development Officer at Geronimo Capital and Director M&A and Corporate Strategy at multi-state cannabis operator Acreage Holdings.

“Bryan combines both the business acumen and institutional knowledge required to grow this organization with the personal passion and understanding of the role cannabis plays at the consumer level,” said the company’s CEO, Mark Ainsworth, on Wednesday .

Vext Science hires Vahan Ajamian as CFO

CBD company Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) has hired veteran cannabis expert Vahan Ajamian to oversee the finance department.

Ajamian, who replaces Denise Lok, will also serve as company secretary, a position held by Brian Cameron.

Eric Offenberger, CEO of the company, praised Ajamian’s skills and expertise in the cannabis industry.

“VEXT is currently in a period of strong growth as the adult application market in Arizona continues to develop and we seek to expand our presence through successful deals in both Arizona and other limited license states,” Offenberger said Wednesday.

In January, the Vancouver-based company secured $ 18 million in an offer to buy its units.

Beacon Securities Ltd. Under the terms of the agreement, decided to purchase 16.1 million units of Vext Science at a price of $ 1.12 per unit.

John M. Hollister of Grapefruit USA resigns

Cannabis company Grapefruit USA Inc. (OTCQB: GPFT) announced on Wednesday that John Hollister has decided to step down.

Hollister was the company’s CEO prior to its reverse takeover by Grapefruit Boulevard Investments, Inc.

Before entering the cannabis sector, Los Angeles based Grapefruit was a 3D imaging developer.

“While we will of course devote most of our time and energy to our rapidly growing cannabis business and the rapid onset of the hourglass era, we intend to use all prudent efforts to maximize the value of our patented 3D imaging technology. whether through sale, development, outsourcing or any other available method, ”stated CEO Bradley Yourist.

© 2021 Benzinga.com. Benzinga does not offer investment advice. All rights reserved.

Comments are closed.